Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Laboratory testing for the new oral anticoagulants: a review of current practice.

× No keyword cloud information.

11 in total

Review 1. Laboratory Assessment of the Anticoagulant Activity of Direct Oral Anticoagulants: A Systematic Review.

Authors: Bethany T Samuelson; Adam Cuker; Deborah M Siegal; Mark Crowther; David A Garcia
Journal: Chest Date: 2016-09-13 Impact factor: 9.410

2. Laboratory monitoring of direct oral anticoagulants (DOACs)-The perfect storm?

Authors: Giuseppe Lippi; Emmanuel J Favaloro
Journal: Ann Transl Med Date: 2017-01

Review 3. Reversal of direct oral anticoagulants: a practical approach.

Authors: Andrew W Shih; Mark A Crowther
Journal: Hematology Am Soc Hematol Educ Program Date: 2016-12-02

Review 4. Laboratory measurement of the non-vitamin K antagonist oral anticoagulants: selecting the optimal assay based on drug, assay availability, and clinical indication.

Authors: Adam Cuker
Journal: J Thromb Thrombolysis Date: 2016-02 Impact factor: 2.300

Review 5. Measurement and reversal of the direct oral anticoagulants.

Authors: Bethany T Samuelson; Adam Cuker
Journal: Blood Rev Date: 2016-09-02 Impact factor: 8.250

Review 6. Laboratory measurement of the anticoagulant activity of the non-vitamin K oral anticoagulants.

Authors: Adam Cuker; Deborah M Siegal; Mark A Crowther; David A Garcia
Journal: J Am Coll Cardiol Date: 2014-09-16 Impact factor: 24.094

7. Novel oral anticoagulants for atrial fibrillation.

Authors: Choon How How
Journal: Singapore Med J Date: 2015-12 Impact factor: 1.858

Review 8. The case for dosing dabigatran: how tailoring dose to patient renal function, weight and age could improve the benefit-risk ratio.

Authors: Apostolos Safouris; Nikos Triantafyllou; John Parissis; Georgios Tsivgoulis
Journal: Ther Adv Neurol Disord Date: 2015-11 Impact factor: 6.570

Review 9. Current use of rivaroxaban in elderly patients with venous thromboembolism (VTE).

Authors: Xin Zhang; Qiyan Cai; Xiaohui Wang; Ke Liao; Changchun Hu; Hong Chen
Journal: J Thromb Thrombolysis Date: 2021-03-05 Impact factor: 2.300

10. Prothrombin complex concentrates and a specific antidote to dabigatran are effective ex-vivo in reversing the effects of dabigatran in an anticoagulation/liver trauma experimental model.

Authors: Oliver Grottke; Joanne van Ryn; Henri M H Spronk; Rolf Rossaint
Journal: Crit Care Date: 2014-02-05 Impact factor: 9.097